Hello, everyone, and nice to see you again. We have finally returned from a brief sojourn and look forward to getting back in the usual groove. The task is made easier now that the short people have left for their respective destinations — the local schoolhouse and gainful employment. Of course, nothing can be accomplished without a few cups of stimulation and we are continuing to enjoy butter pecan. Feel free to join us, whatever your preference. Meanwhile, here are some tidbits. Hope you survive the middle of the week …

Four national organizations representing hospitals sued the federal government over a decision to delay regulations that would require drug makers to disclose the ceiling price for 340B outpatient drugs and to set penalties for overcharging. The Trump administration has delayed implementing the regulations five times and the lawsuit asks a federal court to order the Department of Health and Human Services to make the regulation effective in 30 days on the grounds that the most recent delay is arbitrary, capricious, and unreasonable.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • The claim in DC court against the current Administration’s approach – “the most recent delay is arbitrary, capricious, and unreasonable” – qualifies as a “Sun rises in the East story.” That, at least, is my observation ….

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy